Delivery Order SPE2DR25D1106-SPE2DR26FJB2U
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $25,717.85 to AmerisourceBergen Drug Corp for the supply of AYVAKIT (avapritinib) 200 mg tablets in a 30-count configuration. This firm fixed-price delivery order, issued on November 25, 2025, with an ultimate completion date of December 17, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $48,737.84 firm fixed price delivery order to AmerisourceBergen Drug Corp for AYVAKIT (avapritinib) 25 mg tablets in quantities of 30 units. This award, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, represents a non-competitive, non-set-aside procurement executed as a child order under AmerisourceBergen's broader contract vehicle with DLA. The product will be delivered to AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in a 30-count quantity, with a ceiling value of $24,368.92 and a firm fixed-price structure. This delivery order is not set-aside and represents a competitive award under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion master contract vehicle valued through December 2026 that enables...
- The Defense Logistics Agency awarded a delivery order valued at $51,362.20 to AmerisourceBergen Drug Corp for AYVAKIT (avapritinib) 25 mg tablets in a quantity of 30 units. The contract, issued on December 17, 2025, represents a firm fixed-price delivery order with an ultimate completion date of January 9, 2026. This award was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $25,681.09 to AmerisourceBergen Drug Corp for AYVAKIT 25 mg tablets (30-count supply) on December 5, 2025, with an ultimate completion date of December 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for AYVAKIT 25 mg tablets (30-count packages) valued at $25,681.09 under a firm fixed-price contract type. The award was made on December 3, 2025, with an ultimate completion date of December 24, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order and is a major pharmaceutical distributor...
- This delivery order, valued at $51,362.20, was awarded on November 18, 2025, to AmerisourceBergen Drug Corp for the supply of AYVAKIT (avapritinib) 25 mg tablets in a 30-count package. The award is a firm fixed-price, non-set-aside contract with a completion date of December 10, 2025, and is funded by the Defense Logistics Agency (DLA), a component of the Department of Defense responsible for medical and pharmaceutical supply chain operations. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a $24,368.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AYVAKIT 25 mg tablets (30-count supply) on August 19, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside contract represents a pediatric cancer medication delivery supporting federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for AYVAKIT 25 mg tablets (30-count) under a firm fixed-price contract valued at $24,368.92, with an ultimate completion date of August 21, 2025. This non-competitive delivery order was issued on July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement through DLA's medical supply chain to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for AYVAKIT 25 mg tablets (30-count units) on September 16, 2025, with a ceiling value of $48,737.84 and completion date of October 7, 2025. This firm fixed-price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999 through December 2026. The performance location is...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJB2UDelivery Order
The Defense Logistics Agency awarded a $25,681.09 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AYVAKIT (avapritinib) 25 mg tablets in a 30-count package on November 26, 2025, with completion scheduled for December 18, 2025. This non-competitive delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement valued through December 2026 that serves as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare systems globally. The performance location for this delivery order is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp fulfills ongoing supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its DLA prime vendor contract. AYVAKIT is a specialty oncology medication used in cancer treatment, reflecting the company's role in supplying comprehensive pharmaceutical portfolios including brand-name medications, generics, vaccines, and specialized medical commodities across multiple therapeutic domains to support military medical operations and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.7k | 11/25/25 |